歐洲睪丸素置換療法市場

Abstract

This Frost & Sullivan research service on the European Testosterone Replacement Therapies Market provides an overview of current treatment options, detailed analysis of the market, technological advancements and revenues of the market along with a complete analysis of key market drivers, restraints and trends prevailing in the European market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following markets: transdermal gels, intramuscular injections, patches, orals, buccals and pellets.

This research service is available through our Pharmaceuticals and Biotechnology Growth Partnership Services programme. With this programme, you receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

• Executive Summary of the European Testosterone Replacement Therapies Market
  • Executive Summary

2 RESEARCH METHODOLOGY

• Research Scope and Segmentation
  • Methodology

3 INDUSTRY CHALLENGES

• Challenges Facing the European Testosterone Replacement Therapies Market
  • Industry Challenges

4 EUROPEAN TESTOSTERONE REPLACEMENT THERAPIES MARKET OUTLOOK

• Hypogonadism
  • Description of the Condition
  • Epidemiology
  • Current Treatment Options

5 MARKET ENGINEERING RESEARCH FOR THE EUROPEAN TESTOSTERONE REPLACEMENT THERAPIES MARKET

• Market Engineering Research
  • Market Overview
  • Market Engineering Measurements
  • Market Drivers
  • Market Restraints
  • Revenue Forecasts
  • Trends by Segment
  • End-user Analysis
  • Competitive Landscape

6 COMPETITOR ANALYSIS

• Portfolio Analysis
  • Bayer Schering Pharma AG
  • Ipsen
  • GlaxoSmithKline
  • Ardana Plc
  • Organon
  • ProStrakan Group Plc

7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN TESTOSTERONE REPLACEMENT THERAPIES MARKET

• Strategic Recommendations
  • Market Engineering Recommendations

8 DATABASE OF KEY INDUSTRY PARTICIPANTS

• Key Industry Participants
  • Major Participants

9 APPENDIX

• Decision Support Database
  • Male Population
  • Male Population Over 65 Years
  • Number of Physicians
  • Prevalence of Obese Population Over 15 Years of Age
  • Prostrate Cancer Incidence